Submit a manuscript Sign up for article alerts Contact us Support

About Diabetology & Metabolic Syndrome

This page includes information about the aims and scope of Diabetology & Metabolic Syndrome, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.

By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.

The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.

Diabetology & Metabolic Syndrome reports on basic research and clinical studies in the areas of genetics, pathophysiology, immunology, epidemiology, clinical management, therapeutic strategies, education, nutrition and psychosocial research relevant for the study of diabetes and metabolic syndrome.

Open access

All articles published by Diabetology & Metabolic Syndrome are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Diabetology & Metabolic Syndrome are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Diabetology & Metabolic Syndrome therefore levies an article-processing charge of £1325/$2215/€1600 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.

Indexing services

All articles published in Diabetology & Metabolic Syndrome are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Diabetology & Metabolic Syndrome include:

  • CAS
  • Cases Database
  • Citebase
  • DOAJ
  • Embase
  • Google Scholar
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • Scirus
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

All case reports published in this journal will also be indexed in Cases Database.

Diabetology & Metabolic Syndrome is tracked by Thomson Reuters (ISI) and has an Impact Factor of 1.92.

Publication and peer review process

Criteria for publication

Diabetology & Metabolic Syndrome considers the following types of articles:

  • Research: reports of data from original research and clinical trial outcomes.
  • Reviews: comprehensive, authoritative descriptions of any subject within the scope of the journal.
  • Short reports: brief reports of data from original research.
  • Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.
  • Commentaries: short, focused and opinionated articles on any subject within the scope of the journal. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders.
  • Letters to the Editor: these can take three forms: a substantial re-analysis of a previously published article, or a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers.

Peer review policies

Two or more experts will review submitted manuscripts. The Editor-in-Chief will decide whether manuscripts will be published following peer-review, in consultation with the Editorial Board where necessary.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Diabetology & Metabolic Syndrome, a personalized section of the site.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Diabetology & Metabolic Syndrome will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Diabetology & Metabolic Syndrome should adhere to BioMed Central's editorial policies.

Citing articles in Diabetology & Metabolic Syndrome

Articles in Diabetology & Metabolic Syndrome should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Diabetol Metab Syndr [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Diabetol Metab Syndr 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Diabetology & Metabolic Syndrome?

High visibility

Diabetology & Metabolic Syndrome's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Diabetology & Metabolic Syndrome offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Diabetology & Metabolic Syndrome, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Diabetology & Metabolic Syndrome gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Diabetology & Metabolic Syndrome are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Diabetology & Metabolic Syndrome's pages and on the BioMed Central homepage.

In addition, articles published in Diabetology & Metabolic Syndrome may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Diabetology & Metabolic Syndrome. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Diabetology & Metabolic Syndrome retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.